We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-18.58%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$736M
AUM Growth
-$206M
(-22%)
Cap. Flow
-$15M
Cap. Flow
% of AUM
-2.04%
Top 10 Holdings %
Top 10 Hldgs %
41.67%
Holding
172
New
4
Increased
40
Reduced
22
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$19.6M |
| 2 |
AERI
Aerie Pharmaceuticals
AERI
|
+$16.7M |
| 3 |
Gilead Sciences
GILD
|
+$11.1M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$10.5M |
| 5 |
CELG
Celgene Corp
CELG
|
+$8.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KTWO
K2M Group Holdings, Inc
KTWO
|
+$24.8M |
| 2 |
Johnson & Johnson
JNJ
|
+$16.9M |
| 3 |
Collegium Pharmaceutical
COLL
|
+$14.2M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$13M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 81.78% |
| 2 | Technology | 1.41% |
| 3 | Industrials | 1.2% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VCRA
26
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $10.4M | 1.41% |
264,421
+47,072
| +22% | +$1.7M |
|
|
ADMS
27
DELISTED
Adamas Pharmaceuticals
ADMS
| $9.68M | 1.32% |
1,133,924
+230,500
| +26% | +$3M |
|
|
XLRN
28
DELISTED
Acceleron Pharma
XLRN
| $9.22M | 1.25% |
211,726
-87,000
| -29% | -$4.35M |
|
29
Boston Scientific
BSX
$68.5B
| $8.55M | 1.16% |
241,876
-9,500
| -4% | -$345K |
|
|
RCM
30
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.51M | 1.16% |
1,070,498
+334,775
| +46% | +$2.89M |
|
|
EXAS
31
DELISTED
Exact Sciences
EXAS
| $8.46M | 1.15% |
134,150
-126,900
| -49% | -$8.71M |
|
32
Indaptus Therapeutics
INDP
$231M
| $8.34M | 1.13% |
494
-31
| -6% | -$423K |
|
33
PTC Therapeutics
PTCT
$6.25B
| $8.02M | 1.09% |
233,536
+29,299
| +14% | +$1.05M |
|
34
BioMarin Pharmaceuticals
BMRN
$12B
| $7.8M | 1.06% |
91,621
-93,074
| -50% | -$8.85M |
|
35
Tandem Diabetes Care
TNDM
$1.22B
| $7.71M | 1.05% |
203,067
+160,100
| +373% | +$5.65M |
|
36
Insulet
PODD
$11.6B
| $7.64M | 1.04% |
96,360
| – | – |
|
|
ABMD
37
DELISTED
Abiomed Inc
ABMD
| $7.29M | 0.99% |
22,427
-6,241
| -22% | -$2.17M |
|
|
VRAY
38
DELISTED
ViewRay, Inc.
VRAY
| $7.29M | 0.99% |
1,200,564
+144,400
| +14% | +$1.08M |
|
|
OBSV
39
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $7.15M | 0.97% |
564,692
| – | – |
|
40
Abbott
ABT
$187B
| $7.06M | 0.96% |
97,598
-11,800
| -11% | -$829K |
|
41
iRhythm Holdings
IRTC
$3.86B
| $6.77M | 0.92% |
97,400
-47,300
| -33% | -$3.59M |
|
42
Savara
SVRA
$1.09B
| $6.41M | 0.87% |
846,500
+40,000
| +5% | +$360K |
|
|
SGEN
43
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.35M | 0.86% |
112,029
+98,899
| +753% | +$6.2M |
|
44
Vertex Pharmaceuticals
VRTX
$124B
| $6M | 0.82% |
36,217
-40,629
| -53% | -$7.04M |
|
|
ALBO
45
DELISTED
Albireo Pharma Inc
ALBO
| $5.64M | 0.77% |
229,978
+40,400
| +21% | +$1.07M |
|
46
Biogen
BIIB
$30.4B
| $5.51M | 0.75% |
18,301
+16,639
| +1,001% | +$5.31M |
|
47
Cogent Biosciences
COGT
$6.95B
| $5.5M | 0.75% |
312,536
+50,800
| +19% | +$1.5M |
|
|
EVLO
48
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $5.3M | 0.72% |
20,359
| – | – |
|
|
KA
49
DELISTED
Kineta, Inc. Common Stock
KA
| $5.13M | 0.7% |
+11,298
| New | +$7.66M |
|
|
WCG
50
DELISTED
Wellcare Health Plans, Inc.
WCG
| $4.59M | 0.62% |
19,425
+17,544
| +933% | +$4.7M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Sectoral Asset Management held 172 positions worth $736M, down 22% from $942M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Sectoral Asset Management's Q4 2018 filing shows 4 new, 40 increased, 22 reduced and 68 closed positions. Its largest new stake was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M. The largest sale was K2M Group Holdings, Inc, an estimated $24.8M.
By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 85% a quarter earlier, followed by Technology and Industrials.
- Sectoral Asset Management's largest Q4 2018 buy was Kineta, Inc. Common Stock: 11,298 shares worth $5.13M.
- Sectoral Asset Management added most to Teladoc Health in Q4 2018, an estimated $19.6M increase.
- Sectoral Asset Management's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $16.9M.
- Sectoral Asset Management fully exited K2M Group Holdings, Inc in Q4 2018, selling an estimated $24.8M.
- Sectoral Asset Management's ten largest holdings make up 42% of its $736M portfolio in Q4 2018.
- Sectoral Asset Management opened 4 new positions and closed 68 in Q4 2018.
- Sectoral Asset Management's portfolio value fell 22% quarter-over-quarter to $736M.
Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.